Home Applications Neurological Disease

Neurological Disease

A Wealth of Information
on the Brain

Kinarm can provide objective measures of motor decline, cognitive impairment and loss of inhibitory control currently missing in gold standard assessments.

Better Your Research with Kinarm

Quantify Loss of Inhibitory Control

Inhibitory control can be quantified to help improve motor function.

Measure With Accuracy

Simultaneously measure motor performance (bradykinesia) and response inhibition.
Screen Quickly and Easily.
Rapidly screen for preoperative deficits in inhibitory control.
Help Subjects Recover.
Titrate STN-DBS to maximize the therapeutic benefits on movement, and minimize impaired inhibitory control.
Rapid Screening.
This can be useful in discovering early symptoms of mild cognitive impairment or familial Alzheimer’s.

Articles & Case Studies

Kinarm News

Cerebellar Damage and Proprioception

Relevant Publications

Matthew Green, Yoon No Gregory Hong, Jinsook Roh & Benjamin J. Fregly (2022)

Multibody System Dynamics 56, 313–334. 7-Nov-22. doi.org/10.1007/s11044-022-09847-8

From the author: “This publication lays the computational modeling foundation for development of personalized muscle synergy-based upper extremity exoskeleton controllers that can be used for either robotic assistance or training for stroke subjects.  Our personalized model-based synergy controller will eliminate the possibility of slacking and the need for a reference motion trajectory, since it will use the subject’s own EMG data (combined with Kinarm kinematic data) to inform the personalized model-based controller (no EMG signals, no control torques). The control torques provided by the Kinarm exoskeleton will be based on reshaping of the subject’s neural control rather than errors in the subject’s motion, potentially allowing assistance and training to target the source rather than the symptom of the movement impairment.  “